PL378576A1 - Wytwarzanie podstawionych chinazolin - Google Patents
Wytwarzanie podstawionych chinazolinInfo
- Publication number
- PL378576A1 PL378576A1 PL378576A PL37857604A PL378576A1 PL 378576 A1 PL378576 A1 PL 378576A1 PL 378576 A PL378576 A PL 378576A PL 37857604 A PL37857604 A PL 37857604A PL 378576 A1 PL378576 A1 PL 378576A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- substituted quinazolines
- quinazolines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44509503P | 2003-02-05 | 2003-02-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL378576A1 true PL378576A1 (pl) | 2006-05-02 |
Family
ID=32850969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL378576A PL378576A1 (pl) | 2003-02-05 | 2004-02-03 | Wytwarzanie podstawionych chinazolin |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040158065A1 (pl) |
EP (1) | EP1618095A2 (pl) |
JP (1) | JP2006517959A (pl) |
KR (1) | KR20050095916A (pl) |
CN (1) | CN1745073A (pl) |
AR (1) | AR043027A1 (pl) |
AU (1) | AU2004209452A1 (pl) |
BR (1) | BRPI0407249A (pl) |
CA (1) | CA2514933A1 (pl) |
MX (1) | MXPA05007831A (pl) |
NL (3) | NL1025414C2 (pl) |
PA (1) | PA8595201A1 (pl) |
PE (1) | PE20040945A1 (pl) |
PL (1) | PL378576A1 (pl) |
RU (1) | RU2005122322A (pl) |
TW (1) | TW200420544A (pl) |
UY (1) | UY28177A1 (pl) |
WO (1) | WO2004069791A2 (pl) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU90901A (sh) | 1999-06-21 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg. | Biciklični heterocikli, lekovi koji sadrže ta jedinjenja, njihova primena i postupci za njihovo pripremanje |
US7019012B2 (en) * | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
US7501427B2 (en) | 2003-08-14 | 2009-03-10 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
CN102432552B (zh) * | 2003-08-14 | 2016-01-20 | 阿雷生物药品公司 | 作为受体酪氨酸激酶抑制剂的喹唑啉类似物 |
DE10349113A1 (de) * | 2003-10-17 | 2005-05-12 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Aminocrotonylverbindungen |
EP1746999B1 (en) | 2004-05-06 | 2011-11-16 | Warner-Lambert Company LLC | 4-phenylamino-quinazolin-6-yl-amides |
KR100735639B1 (ko) * | 2004-12-29 | 2007-07-04 | 한미약품 주식회사 | 암세포 성장 억제 효과를 갖는 퀴나졸린 유도체 및 이의제조방법 |
KR100832594B1 (ko) * | 2005-11-08 | 2008-05-27 | 한미약품 주식회사 | 다중저해제로서의 퀴나졸린 유도체 및 이의 제조방법 |
CA2833706C (en) | 2005-11-11 | 2014-10-21 | Boehringer Ingelheim International Gmbh | Quinazoline derivatives for the treatment of cancer diseases |
CA2755268C (en) * | 2005-11-15 | 2013-12-31 | Array Biopharma, Inc. | Erbb inhibitors |
MX2009002710A (es) * | 2006-09-18 | 2009-03-25 | Boehringer Ingelheim Int | Metodos para tratar canceres que portan mutaciones de egfr. |
WO2009035718A1 (en) * | 2007-09-10 | 2009-03-19 | Curis, Inc. | Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
EP2242493B1 (en) * | 2008-01-22 | 2013-06-05 | Concert Pharmaceuticals Inc. | Derivatives of gefitinib |
WO2009094210A1 (en) * | 2008-01-22 | 2009-07-30 | Concert Pharmaceuticals Inc. | Vandetanib derivatives |
CN102405284B (zh) * | 2008-09-05 | 2016-01-20 | 新基阿维罗米克斯研究公司 | 设计不可逆抑制剂的算法 |
SI2451445T1 (sl) | 2009-07-06 | 2019-07-31 | Boehringer Ingelheim International Gmbh | Postopek za sušenje BIBW2992, njegovih soli in trdnih farmacevtskih formulacij, ki obsegajo to aktivno sestavino |
RU2012114902A (ru) | 2009-09-16 | 2013-10-27 | Авила Терапьютикс, Инк. | Конъюгаты и ингибиторы протеинкиназы |
CA2785738A1 (en) | 2009-12-30 | 2011-07-07 | Avila Therapeutics, Inc. | Ligand-directed covalent modification of protein |
CN102382106A (zh) | 2010-08-30 | 2012-03-21 | 黄振华 | 苯胺取代的喹唑啉衍生物 |
WO2013013640A1 (zh) * | 2011-07-27 | 2013-01-31 | 上海医药集团股份有限公司 | 喹唑啉衍生物、其制备方法、中间体、组合物及其应用 |
JP2014532063A (ja) * | 2011-10-12 | 2014-12-04 | テリジェン リミテッドTeligene Ltd | キナーゼ阻害剤としてのキナゾリン誘導体およびその使用方法 |
US9388170B2 (en) | 2012-05-07 | 2016-07-12 | Teligene Ltd. | Substituted aminoquinazolines useful as kinases inhibitors |
CN103965120B (zh) * | 2013-01-25 | 2016-08-17 | 上海医药集团股份有限公司 | 喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用 |
CN103242244B (zh) * | 2013-05-16 | 2015-03-25 | 苏州明锐医药科技有限公司 | 一种卡奈替尼的制备方法 |
CN105408334B (zh) | 2013-05-21 | 2017-10-10 | 江苏迈度药物研发有限公司 | 作为激酶抑制剂的取代的吡唑并嘧啶类化合物 |
US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
CN107868059B (zh) * | 2016-09-23 | 2022-07-19 | 上海医药集团股份有限公司 | 一种喹唑啉衍生物的盐、其制备方法及应用 |
ES2910071T3 (es) | 2018-03-08 | 2022-05-11 | Incyte Corp | Compuestos de aminopirazina diol como inhibidores de PI3K-Y |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
JP2022502495A (ja) | 2018-09-25 | 2022-01-11 | ブラック ダイアモンド セラピューティクス,インコーポレイティド | チロシンキナーゼ阻害剤としてのキナゾリン誘導体、組成物、それらの作製方法、およびそれらの使用 |
WO2020178434A1 (en) * | 2019-03-07 | 2020-09-10 | BioNTech SE | Process for the preparation of a substituted imidazoquinoline |
EP4328222A1 (en) * | 2021-04-22 | 2024-02-28 | Voronoi Inc. | Heteroaryl derivative compound and use thereof |
WO2023044364A1 (en) | 2021-09-15 | 2023-03-23 | Enko Chem, Inc. | Protoporphyrinogen oxidase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL190489B1 (pl) * | 1996-04-12 | 2005-12-30 | Warner Lambert Co | Nieodwracalne inhibitory kinaz tyrozyny, kompozycja farmaceutyczna je zawierająca i ich zastosowanie |
US6664390B2 (en) * | 2000-02-02 | 2003-12-16 | Warner-Lambert Company Llc | Method for the simplified production of (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine |
DE10009267A1 (de) * | 2000-02-26 | 2001-08-30 | Goedecke Ag | Verfahren zur einfachen Herstellung von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amin bzw. (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazolin-4-yl]-amin |
US6627634B2 (en) * | 2000-04-08 | 2003-09-30 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
DE10063435A1 (de) * | 2000-12-20 | 2002-07-04 | Boehringer Ingelheim Pharma | Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
-
2004
- 2004-02-02 PE PE2004000120A patent/PE20040945A1/es not_active Application Discontinuation
- 2004-02-03 JP JP2006502417A patent/JP2006517959A/ja not_active Abandoned
- 2004-02-03 TW TW093102396A patent/TW200420544A/zh unknown
- 2004-02-03 CA CA002514933A patent/CA2514933A1/en not_active Abandoned
- 2004-02-03 PL PL378576A patent/PL378576A1/pl not_active Application Discontinuation
- 2004-02-03 RU RU2005122322/04A patent/RU2005122322A/ru not_active Application Discontinuation
- 2004-02-03 MX MXPA05007831A patent/MXPA05007831A/es unknown
- 2004-02-03 WO PCT/IB2004/000321 patent/WO2004069791A2/en active Application Filing
- 2004-02-03 CN CNA2004800032079A patent/CN1745073A/zh active Pending
- 2004-02-03 KR KR1020057014036A patent/KR20050095916A/ko not_active Application Discontinuation
- 2004-02-03 AU AU2004209452A patent/AU2004209452A1/en not_active Abandoned
- 2004-02-03 EP EP04707601A patent/EP1618095A2/en not_active Withdrawn
- 2004-02-03 BR BR0407249-9A patent/BRPI0407249A/pt not_active IP Right Cessation
- 2004-02-04 UY UY28177A patent/UY28177A1/es not_active Application Discontinuation
- 2004-02-04 US US10/771,774 patent/US20040158065A1/en not_active Abandoned
- 2004-02-04 AR ARP040100350A patent/AR043027A1/es unknown
- 2004-02-05 PA PA20048595201A patent/PA8595201A1/es unknown
- 2004-02-05 NL NL1025414A patent/NL1025414C2/nl not_active IP Right Cessation
-
2005
- 2005-08-18 NL NL1029763A patent/NL1029763C2/nl not_active IP Right Cessation
- 2005-08-18 NL NL1029762A patent/NL1029762C2/nl not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1745073A (zh) | 2006-03-08 |
BRPI0407249A (pt) | 2006-01-31 |
TW200420544A (en) | 2004-10-16 |
RU2005122322A (ru) | 2006-03-10 |
WO2004069791A3 (en) | 2004-12-16 |
UY28177A1 (es) | 2004-09-30 |
WO2004069791A2 (en) | 2004-08-19 |
NL1025414C2 (nl) | 2005-11-01 |
EP1618095A2 (en) | 2006-01-25 |
NL1029762C2 (nl) | 2006-03-06 |
JP2006517959A (ja) | 2006-08-03 |
MXPA05007831A (es) | 2005-10-18 |
AR043027A1 (es) | 2005-07-13 |
AU2004209452A1 (en) | 2004-08-19 |
CA2514933A1 (en) | 2004-08-19 |
NL1029763C2 (nl) | 2006-03-06 |
PE20040945A1 (es) | 2004-12-14 |
NL1029762A1 (nl) | 2005-10-13 |
US20040158065A1 (en) | 2004-08-12 |
NL1029763A1 (nl) | 2005-10-13 |
PA8595201A1 (es) | 2004-09-16 |
NL1025414A1 (nl) | 2004-08-06 |
KR20050095916A (ko) | 2005-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL378576A1 (pl) | Wytwarzanie podstawionych chinazolin | |
ZA200605348B (en) | Solid forms of anti-EGFR-antibodies | |
GB0322409D0 (en) | Quinazoline derivatives | |
IL174534A0 (en) | Quinazoline derivatives | |
HK1091489A1 (en) | Quinazoline derivatives | |
IL174257A0 (en) | Quinazoline derivatives | |
GB0321648D0 (en) | Quinazoline derivatives | |
IL175421A0 (en) | Quinazoline derivatives | |
EP1745573A4 (en) | PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES | |
IL174390A0 (en) | Quinazoline derivatives | |
GB0421149D0 (en) | Preparation of oxycodone | |
GB0200744D0 (en) | Preparation of nanoparticles | |
GB0330002D0 (en) | Quinazoline derivatives | |
ZA200603039B (en) | Quinazoline derivatives | |
GB0304555D0 (en) | Compounds and methods of manufacture | |
AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
GB0321620D0 (en) | Quinazoline derivatives | |
ZA200505214B (en) | Preparation of quinapril hydrochloride | |
PL377902A1 (pl) | Nowe zastosowanie kompleksu fosfor-azot-metal | |
AU152108S (en) | Set of pavers | |
IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
GB0318915D0 (en) | Construction of aerials | |
TW561865U (en) | Improvement of curtain | |
TW553243U (en) | Structure of clotheshanger | |
TW582219U (en) | Improved structure of flabellum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |